Scholars@Duke
Journal cover image

Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis.

Publication ,  Journal Article
Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators
Published in: Neuroepidemiology
2003
Published version (DOI) Link to item

Duke Scholars

Andrzej Stanislaw Kosinski
Author Andrzej Stanislaw Kosinski Biostatistics & Bioinformatics, Division of Biostatistics

Published In

Neuroepidemiology

DOI

10.1159/000068744

ISSN

0251-5350

Publication Date

2003

Volume

22

Issue

2

Start / End Page

106 / 117

Location

Switzerland

Related Subject Headings

  • Warfarin
  • Time Factors
  • Survival Rate
  • Stroke
  • Research Design
  • Prospective Studies
  • Program Development
  • Platelet Aggregation Inhibitors
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. (2003). Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology, 22(2), 106–117. https://doi.org/10.1159/000068744
Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. “Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis.” Neuroepidemiology 22, no. 2 (2003): 106–17. https://doi.org/10.1159/000068744.
Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology. 2003;22(2):106–17.
Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. “Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis.” Neuroepidemiology, vol. 22, no. 2, 2003, pp. 106–17. Pubmed, doi:10.1159/000068744.
Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology. 2003;22(2):106–117.
Journal cover image

Published In

Neuroepidemiology

DOI

10.1159/000068744

ISSN

0251-5350

Publication Date

2003

Volume

22

Issue

2

Start / End Page

106 / 117

Location

Switzerland

Related Subject Headings

  • Warfarin
  • Time Factors
  • Survival Rate
  • Stroke
  • Research Design
  • Prospective Studies
  • Program Development
  • Platelet Aggregation Inhibitors
  • Middle Aged
  • Male